Medicinal Plants | ~4 min read The market is splitting in two and pharma-grade botanical nutraceutical is one of them For years, the nutraceutical industry sourced botanical ingredients the same way the food industry sourced spices: in bulk, from commodity suppliers, with minimal documentation beyond a basic certificate of analysis. The primary selection criteria were price per kilogram and availability. For many products, this was adequate. A dried leaf blend destined for

BotaniX expertise | ~4 min read Dried plant material was the default, but that is changing. For most of the history of botanical ingredient supply, the standard format was simple: dried plant material, ground to a coarse or medium powder, shipped in bulk. Formulators received it, tested it, and worked with whatever particle size distribution the supplier delivered. The result was adequate for many applications, but it introduced variability at the formulation stage that man

The Forgotten Half of the Plant When we think of medicinal plants, we usually picture leaves, flowers, and stems. These aerial parts are the most accessible, the most studied, and the easiest to harvest at scale. But for many therapeutically important species, the root system contains a distinct and often more concentrated set of bioactive compounds that have been largely overlooked by the modern ingredients industry.

Traceability Is No Longer Optional The days when "natural origin" was a sufficient quality claim for botanical ingredients are over. Today’s regulatory environment, from EU CSRD reporting to tightening pharmacopeial standards, demands that companies demonstrate exactly where their ingredients come from, how they were produced, and what quality controls were applied at every step.